US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Aug 8, 2025 (13 months ago)

Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the long-term shelf life stability interval, wherein the dissolution results do not comply with L3 stage dissolution criteria.

What was recalled

Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited, Colvale-Bardez, Goa- 403513 India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ, NDC 68462-380-01

Recalling firm
Glenmark Pharmaceuticals Inc., USA
NDC code
68462-380-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0583-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Theophylline recalls

See all